Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-UK bluechips give up gains as sterling strengthens

Mon, 09th Sep 2019 09:52

* FTSE 100 down 0.6%, FTSE 250 down 0.1%

* Multinationals drop as pound gains

* ABF falls after weak trading update

* Shopping centre operator Intu jumps on deal report
(Adds company news items, updates share moves)

By Muvija M and Indranil Sarkar

Sept 9 (Reuters) - London's FTSE 100 fell on Monday as the
pound ploughed ahead after unexpectedly robust economic data and
as no-deal Brexit worries tempered, leaving
internationally-focussed stocks in the dumps.

The blue-chip index lost 0.6%, shedding earlier
gains and lagging its European peers, due to steep falls in
pharmaceutical shares AstraZeneca, GlaxoSmithKline
, and consumer goods giant Unilever.

The FTSE 250 index dipped 0.1%, though losses were
limited thanks to a 10.4% surge in Intu Properties
after the Times reported that private equity firm Orion Capital
Managers was looking to buy the shopping centre operator.

Sterling scaled a six-week high as fears of a recession were
kept in check after data showed Britain's economy picked up more
than expected in July despite Brexit uncertainty.

However, the local currency handed back some of those gains
after news that John Bercow, Speaker in Britain's House of
Commons, would be standing down from the role.

Over three years after Britain voted to leave the European
Union, matters have only gotten more complicated as the process
plays out.

In the latest twist, parliament passed a bill demanding that
Prime Minister Boris Johnson delay Brexit unless he strikes a
new deal, while his office insisted that Brexit would happen on
Oct. 31, "no ifs and buts".

A NO DEAL OR A NEW REFERENDUM

"An unsettled UK political and economic landscape could be
with us for some time," BlackRock analysts wrote in their weekly
note.

"Six months ago, a negotiated deal looked most likely; now,
the then-extreme outcomes – no-deal or a new referendum – look
to have become more plausible."

Helping contain losses on the main bourse were oil majors
Shell and BP, both of which eked out near 1%
gains on hopes that Saudi Arabia's new energy minister will
continue to support output cuts.

Elsewhere, Wall Street indexes gained on growing hopes that
central banks will step in with stimulus plans after a data
showed an unexpected fall in China's exports last month, while
another one pointed to a slowdown in Japan's economy in the
second quarter.

The weakness reflected an impact from the prolonged
Sino-U.S. trade war to global economic growth.

The dispute saw a sharp escalation last month when the
United States announced higher tariffs on Chinese goods. That
had dragged the FTSE 100 to its biggest monthly fall so far this
year that month.

On Monday, the index saw some news-related falls, with
Associated British Foods losing 2.1% after poor outlook
for its Primark fashion chain and British Airways owner IAG
dropping 1.5% as it cancelled nearly all its flights
due to strikes.
(Reporting by Indranil Sarkar in Bengaluru; editing by Arun
Koyyur and Toby Chopra)

More News
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.